Zevra Therapeutics (ZVRA) announced the appointment of Alicia Secor to the Company’s Board of Directors. The Company announced the retirement of director Wendy Dixon, PhD, effective today.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVRA:
- Zevra Therapeutics CFO Resignation Announced
- Zevra Therapeutics CFO R. LaDuane Clifton to step down
- Zevra Therapeutics: Strategic Focus on Miplyffa Drives Buy Rating Amid Promising Growth Prospects
- Zevra Therapeutics Reports Strong Q3 Earnings and Strategic Growth
- Zevra Therapeutics price target lowered to $24 from $29 at Cantor Fitzgerald